United States Biodefense Market Report & Forecast 2021-2027

1 Introduction to Research & Analysis Reports
1.1 Biodefense Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Biodefense Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 United States Biodefense Overall Market Size
2.1 United States Biodefense Market Size: 2021 VS 2027
2.2 United States Biodefense Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints

3 Company Landscape
3.1 Top Biodefense Players in United States Market
3.2 Top United States Biodefense Companies Ranked by Revenue
3.3 United States Biodefense Revenue by Companies
3.4 Top 3 and Top 5 Biodefense Companies in United States Market, by Revenue in 2020
3.5 Companies Biodefense Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biodefense Players in United States Market
3.6.1 List of Tier 1 Biodefense Companies in United States
3.6.2 List of Tier 2 and Tier 3 Biodefense Companies in United States

4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Biodefense Market Size Markets, 2021 & 2027
4.1.2 Anthrax
4.1.3 Smallpox
4.1.4 Botulism
4.1.5 Radiation/Nuclear
4.1.6 Others
4.2 By Type - United States Biodefense Revenue & Forecasts
4.2.1 By Type - United States Biodefense Revenue, 2016-2021
4.2.2 By Type - United States Biodefense Revenue, 2022-2027
4.2.3 By Type - United States Biodefense Revenue Market Share, 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Biodefense Market Size, 2021 & 2027
5.1.2 US Military Market
5.1.3 US Civilian Market
5.1.4 Non - US Market
5.2 By Application - United States Biodefense Revenue & Forecasts
5.2.1 By Application - United States Biodefense Revenue, 2016-2021
5.2.2 By Application - United States Biodefense Revenue, 2022-2027
5.2.3 By Application - United States Biodefense Revenue Market Share, 2016-2027

6 Biodefense Companies Profiles
6.1 Emergent Biosolutions
6.1.1 Emergent Biosolutions Company Details
6.1.2 Emergent Biosolutions Business Overview
6.1.3 Emergent Biosolutions Biodefense Introduction
6.1.4 Emergent Biosolutions Biodefense Revenue in United States Market (2016-2021)
6.1.5 Emergent Biosolutions Recent Developments
6.2 Hytest
6.2.1 Hytest Company Details
6.2.2 Hytest Business Overview
6.2.3 Hytest Biodefense Introduction
6.2.4 Hytest Biodefense Revenue in United States Market (2016-2021)
6.2.5 Hytest Recent Developments
6.3 GSK
6.3.1 GSK Company Details
6.3.2 GSK Business Overview
6.3.3 GSK Biodefense Introduction
6.3.4 GSK Biodefense Revenue in United States Market (2016-2021)
6.3.5 GSK Recent Developments
6.4 Sanofi
6.4.1 Sanofi Company Details
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Biodefense Introduction
6.4.4 Sanofi Biodefense Revenue in United States Market (2016-2021)
6.4.5 Sanofi Recent Developments
6.5 PharmAthene
6.5.1 PharmAthene Company Details
6.5.2 PharmAthene Business Overview
6.5.3 PharmAthene Biodefense Introduction
6.5.4 PharmAthene Biodefense Revenue in United States Market (2016-2021)
6.5.5 PharmAthene Recent Developments
6.6 Bavarian Nordic
6.6.1 Bavarian Nordic Company Details
6.6.2 Bavarian Nordic Business Overview
6.6.3 Bavarian Nordic Biodefense Introduction
6.6.4 Bavarian Nordic Biodefense Revenue in United States Market (2016-2021)
6.6.5 Bavarian Nordic Recent Developments
6.7 SIGA Technologies
6.7.1 SIGA Technologies Company Details
6.7.2 SIGA Technologies Business Overview
6.7.3 SIGA Technologies Biodefense Introduction
6.7.4 SIGA Technologies Biodefense Revenue in United States Market (2016-2021)
6.7.5 SIGA Technologies Recent Developments
6.8 Arbutus Biopharma
6.8.1 Arbutus Biopharma Company Details
6.8.2 Arbutus Biopharma Business Overview
6.8.3 Arbutus Biopharma Biodefense Introduction
6.8.4 Arbutus Biopharma Biodefense Revenue in United States Market (2016-2021)
6.8.5 Arbutus Biopharma Recent Developments
6.9 DynPort Vaccine
6.9.1 DynPort Vaccine Company Details
6.9.2 DynPort Vaccine Business Overview
6.9.3 DynPort Vaccine Biodefense Introduction
6.9.4 DynPort Vaccine Biodefense Revenue in United States Market (2016-2021)
6.9.5 DynPort Vaccine Recent Developments
6.10 Xoma Corporation
6.10.1 Xoma Corporation Company Details
6.10.2 Xoma Corporation Business Overview
6.10.3 Xoma Corporation Biodefense Introduction
6.10.4 Xoma Corporation Biodefense Revenue in United States Market (2016-2021)
6.10.5 Xoma Corporation Recent Developments
6.11 Ichor Medical Systems
6.11.1 Ichor Medical Systems Company Details
6.11.2 Ichor Medical Systems Business Overview
6.11.3 Ichor Medical Systems Biodefense Introduction
6.11.4 Ichor Medical Systems Biodefense Revenue in United States Market (2016-2021)
6.11.5 Ichor Medical Systems Recent Developments
6.12 Aeolus Pharmaceuticals
6.12.1 Aeolus Pharmaceuticals Company Details
6.12.2 Aeolus Pharmaceuticals Business Overview
6.12.3 Aeolus Pharmaceuticals Biodefense Introduction
6.12.4 Aeolus Pharmaceuticals Biodefense Revenue in United States Market (2016-2021)
6.12.5 Aeolus Pharmaceuticals Recent Developments
6.13 Achaogen
6.13.1 Achaogen Company Details
6.13.2 Achaogen Business Overview
6.13.3 Achaogen Biodefense Introduction
6.13.4 Achaogen Biodefense Revenue in United States Market (2016-2021)
6.13.5 Achaogen Recent Developments
6.14 Elusys Therapeutics
6.14.1 Elusys Therapeutics Company Details
6.14.2 Elusys Therapeutics Business Overview
6.14.3 Elusys Therapeutics Biodefense Introduction
6.14.4 Elusys Therapeutics Biodefense Revenue in United States Market (2016-2021)
6.14.5 Elusys Therapeutics Recent Developments
6.15 Dynavax Technologies
6.15.1 Dynavax Technologies Company Details
6.15.2 Dynavax Technologies Business Overview
6.15.3 Dynavax Technologies Biodefense Introduction
6.15.4 Dynavax Technologies Biodefense Revenue in United States Market (2016-2021)
6.15.5 Dynavax Technologies Recent Developments
6.16 Cleveland BioLabs
6.16.1 Cleveland BioLabs Company Details
6.16.2 Cleveland BioLabs Business Overview
6.16.3 Cleveland BioLabs Biodefense Introduction
6.16.4 Cleveland BioLabs Biodefense Revenue in United States Market (2016-2021)
6.16.5 Cleveland BioLabs Recent Developments
6.17 Soligenix
6.17.1 Soligenix Company Details
6.17.2 Soligenix Business Overview
6.17.3 Soligenix Biodefense Introduction
6.17.4 Soligenix Biodefense Revenue in United States Market (2016-2021)
6.17.5 Soligenix Recent Developments
6.18 Alnylam Pharmaceuticals
6.18.1 Alnylam Pharmaceuticals Company Details
6.18.2 Alnylam Pharmaceuticals Business Overview
6.18.3 Alnylam Pharmaceuticals Biodefense Introduction
6.18.4 Alnylam Pharmaceuticals Biodefense Revenue in United States Market (2016-2021)
6.18.5 Alnylam Pharmaceuticals Recent Developments

7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer

List of Tables
Table 1. Biodefense Market Opportunities & Trends in United States Market
Table 2. Biodefense Market Drivers in United States Market
Table 3. Biodefense Market Restraints in United States Market
Table 4. Key Players of Biodefense in United States Market
Table 5. Top Biodefense Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Biodefense Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Biodefense Revenue Share by Companies, 2016-2021
Table 8. Companies Biodefense Product Type
Table 9. List of Tier 1 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Biodefense Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – United States Biodefense Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Biodefense Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Biodefense Revenue (US$, Mn), 2022-2027
Table 14. By Application – United States Biodefense Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Biodefense Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Biodefense Revenue (US$, Mn), 2022-2027
Table 17. Emergent Biosolutions Company Details
Table 18. Emergent Biosolutions Business Overview
Table 19. Emergent Biosolutions Biodefense Product
Table 20. Emergent Biosolutions Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. Emergent Biosolutions Recent Developments
Table 22. Hytest Company Details
Table 23. Hytest Business Overview
Table 24. Hytest Biodefense Product
Table 25. Hytest Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Hytest Recent Developments
Table 27. GSK Company Details
Table 28. GSK Business Overview
Table 29. GSK Biodefense Product
Table 30. GSK Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. GSK Recent Developments
Table 32. Sanofi Company Details
Table 33. Sanofi Business Overview
Table 34. Sanofi Biodefense Product
Table 35. Sanofi Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Sanofi Recent Developments
Table 37. PharmAthene Company Details
Table 38. PharmAthene Business Overview
Table 39. PharmAthene Biodefense Product
Table 40. PharmAthene Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. PharmAthene Recent Developments
Table 42. Bavarian Nordic Company Details
Table 43. Bavarian Nordic Business Overview
Table 44. Bavarian Nordic Biodefense Product
Table 45. Bavarian Nordic Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. Bavarian Nordic Recent Developments
Table 47. SIGA Technologies Company Details
Table 48. SIGA Technologies Business Overview
Table 49. SIGA Technologies Biodefense Product
Table 50. SIGA Technologies Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. SIGA Technologies Recent Developments
Table 52. Arbutus Biopharma Company Details
Table 53. Arbutus Biopharma Business Overview
Table 54. Arbutus Biopharma Biodefense Product
Table 55. Arbutus Biopharma Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. Arbutus Biopharma Recent Developments
Table 57. DynPort Vaccine Company Details
Table 58. DynPort Vaccine Business Overview
Table 59. DynPort Vaccine Biodefense Product
Table 60. DynPort Vaccine Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. DynPort Vaccine Recent Developments
Table 62. Xoma Corporation Company Details
Table 63. Xoma Corporation Business Overview
Table 64. Xoma Corporation Biodefense Product
Table 65. Xoma Corporation Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Xoma Corporation Recent Developments
Table 67. Ichor Medical Systems Company Details
Table 68. Ichor Medical Systems Business Overview
Table 69. Ichor Medical Systems Biodefense Product
Table 70. Ichor Medical Systems Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Ichor Medical Systems Recent Developments
Table 72. Aeolus Pharmaceuticals Company Details
Table 73. Aeolus Pharmaceuticals Business Overview
Table 74. Aeolus Pharmaceuticals Biodefense Product
Table 75. Aeolus Pharmaceuticals Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 76. Aeolus Pharmaceuticals Recent Developments
Table 77. Achaogen Company Details
Table 78. Achaogen Business Overview
Table 79. Achaogen Biodefense Product
Table 80. Achaogen Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 81. Achaogen Recent Developments
Table 82. Elusys Therapeutics Company Details
Table 83. Elusys Therapeutics Business Overview
Table 84. Elusys Therapeutics Biodefense Product
Table 85. Elusys Therapeutics Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 86. Elusys Therapeutics Recent Developments
Table 87. Dynavax Technologies Business Overview
Table 88. Dynavax Technologies Company Details
Table 89. Dynavax Technologies Biodefense Product
Table 90. Dynavax Technologies Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 91. Dynavax Technologies Recent Developments
Table 92. Cleveland BioLabs Company Details
Table 93. Cleveland BioLabs Business Overview
Table 94. Cleveland BioLabs Biodefense Product
Table 95. Cleveland BioLabs Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 96. Cleveland BioLabs Recent Developments
Table 97. Soligenix Company Details
Table 98. Soligenix Business Overview
Table 99. Soligenix Biodefense Product
Table 100. Soligenix Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 101. Soligenix Recent Developments
Table 102. Alnylam Pharmaceuticals Company Details
Table 103. Alnylam Pharmaceuticals Business Overview
Table 104. Alnylam Pharmaceuticals Biodefense Product
Table 105. Alnylam Pharmaceuticals Biodefense Revenue in United States Market (2016-2021) & (US$ Million)
Table 106. Alnylam Pharmaceuticals Recent Developments
List of Figures
Figure 1. Biodefense Segment by Type
Figure 2. Biodefense Segment by Application
Figure 3. United States Biodefense Market Overview: 2020
Figure 4. United States Biodefense Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Biodefense Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Biodefense Revenue in 2020
Figure 7. By Type - United States Biodefense Revenue Market Share, 2016-2027
Figure 8. By Application - United States Biodefense Revenue Market Share, 2016-2027
Figure 9. Emergent Biosolutions Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Hytest Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GSK Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sanofi Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. PharmAthene Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Bavarian Nordic Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. SIGA Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Arbutus Biopharma Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. DynPort Vaccine Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Xoma Corporation Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Ichor Medical Systems Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Aeolus Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Achaogen Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Elusys Therapeutics Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Dynavax Technologies Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Cleveland BioLabs Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Soligenix Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Alnylam Pharmaceuticals Biodefense Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.